Table 3: Antiviral activity of prokaryotic cyanobacterial polysaccharides .
Cyanobacteria |
Compounds |
Mechanism of action |
Virus |
In vitro/In vivo |
Reference |
Arthrospira platensis |
calcium spirulan |
Inhibition of cytopathic effects and syncytium formation |
HSV-1 and HIV-1 |
In vitro (MT-4,19 Molt-4 clone No. 8,20 cells, Molt-4/HTLV-IIIB21 cells and HeLa cells) |
|
Arthrospira maxima |
Polysaccharide |
Inhibition of virus absorption and penetration |
HSV-1, HSV-2, pseudorabies virus, and human cytomegalovirus |
In vitro |
|
Nostoc flagelliforme |
Acidic polysaccharide (nostoflan) |
Inhibition of virus absorption |
Influenza A virus, HSV-1, HSV-2, human cytomegalovirus |
In vitro (Vero, HEL, MDCK, and HeLa cells) |
|
Arthrospira platensis |
Polysaccharide (spirulan-like molecules) |
Inhibition of viral entry and protein synthesis |
Human cytomegalovirus, HSV-1, human herpesvirus type 6 and HIV-1 |
In vitro (Primary human foreskin fibroblasts, Vero, 293T cells and MDCK cells) |
|
Arthrospira platensis |
Anionic exopolysaccharide (TK V3) |
Inhibition of entry |
Vaccinia virus and Ectromelia virus |
In vitro (HEp-2 cells and Vero cells) |